Existing studies have shown that simultaneous morphological pathological diagnosis and BRAF V600E gene mutation detection in thyroid fine-needle aspiration biopsy samples can reduce the missed diagnosis rate of suspicious papillary thyroid carcinoma by 52% (9–11). This evidence concerns the gene BRAF and differentiated thyroid carcinoma.